# PulseID — Product Scope Specification

## 1. Executive Summary

**PulseID** is a next-generation healthcare technology platform designed to streamline, secure, and interconnect medical workflows between three core stakeholders: **Patients**, **Doctors**, and **Pharmacists**.

While the full medical platform encompasses clinical diagnostics, electronic prescribing, patient medical identification, and drug-interaction monitoring, the immediate project priority is establishing a solid frontend foundation and publishing a high-converting, professional **public one-page launch landing page targeting 20 November 2026**.

---

## 2. Confirmed Requirements

1. **Platform Identity:**
   - Name: `PulseID`.
   - Core positioning: A connected, secure healthcare technology ecosystem.
2. **Three Core User Audiences:**
   - **Patients:** Individual health profiles, personal medical records, digital medical identity, and prescription access.
   - **Doctors:** Clinical consultation views, patient history exploration, diagnostic notation, and electronic prescription generation.
   - **Pharmacists:** Prescription validation, dispensing verification queues, and drug interaction safety checks.
3. **Immediate Deliverable (Phase 2):**
   - A single, public, one-page launch website.
   - Clear launch target date displayed: **20 November 2026**.
   - No backend or database required for the initial phase.
   - Server-first, highly responsive, and accessible.
4. **Non-Goals for Current & Immediate Phases:**
   - No patient portal implementation.
   - No doctor portal implementation.
   - No pharmacist portal implementation.
   - No optical character recognition (OCR) or AI clinical assistant modules.
   - No backend APIs, microservices, or database schemas.

---

## 3. Proposed Decisions

1. **Launch Landing Page Strategy:**
   - **Audience:** Early-adopter medical practitioners, healthcare clinic directors, prospective patients, and institutional pharmacy partners.
   - **Primary Objective:** Build credibility, communicate the unified healthcare vision, and collect waitlist / early access registrations.
   - **Key Functional Sections:**
     1. *Hero Section:* Clear value proposition, launch date countdown/announcement, primary CTA.
     2. *Role Ecosystem Overview:* Highlighting the three personas (Patient, Doctor, Pharmacist) and how PulseID bridges their daily interactions.
     3. *Trust & Security Foundations:* High-level statement on compliance, data integrity, and patient privacy.
     4. *Waitlist / Early Access Invitation:* Simple email capture form.
     5. *Footer:* Essential legal, privacy, and copyright disclosures.
2. **Phase Boundary Enforcement:**
   - All medical application routes and layouts remain gated until Phase 2 is successfully released and signed off.

---

## 4. Open Questions

1. **Waitlist Collection Infrastructure:**
   - What backend or third-party service will capture waitlist submissions during Phase 2? (e.g., lightweight Next.js Server Action with Airtable/Resend/Supabase/webhook, or pure static mailto link initially?).
2. **Brand Assets & Imagery:**
   - Will dedicated vector logos, brand palettes, or clinical photography assets be provided before implementing Phase 2?
3. **Regulatory Jurisdiction Targeting:**
   - Which primary regions should the initial messaging emphasize? (e.g., US HIPAA compliance, EU GDPR/MDR compliance, or regional health authorities).
